Florence Sejourne - Genfit SA Insider

GNFTF -- USA Stock  

USD 27.55  0.000001  0.00%

Member of the Supervisory Board, Representative of Biotech Avenir

Ms. Florence Sejourne has served as Member of the Supervisory Board, Representative of Biotech Avenir at Genfit SA since June 14, 2010. Prior to this, she was Member of the Management Board and Director of Operations of the Company from September 15, 1999 to May 28, 2008. She was Member of the Management Committee of Biotech Avenir and Cadialpha and Member of the Management Board of IT.Omics. She started her professional career in the immunology research department of Centre de Recherche Roussel Uclaf in Romainville, France. Between 1994 and 1996, she worked within the pharmaceutical department of the University of Illinois, Chicago. In 1997, she joined Eurasante as Head of the Biopharmaceutical department. She has a Masters degree in Pharmaceutical Studies from the University of Illinois and a degree in Biotechnology from Ecole des Mines de Paris.
  Executive Since 2010      
33 3 20 16 40 00  http://www.genfit.com

Management Efficiency

The company has return on total asset (ROA) of (15.42) % which means that it has lost $15.42 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (47.45) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 201.36 M in total debt with debt to equity ratio (D/E) of 157.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Genfit SA has Current Ratio of 10.25 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver worldwide. Genfit SA was founded in 1999 and is headquartered in Loos, France. Genfit SA operates under Biotechnology classification in USA and traded on OTC Market. It employs 125 people.Genfit SA (GNFTF) is traded on OTC Market in USA. It is located in Parc Eurasant? and employs 125 people.

Genfit SA Leadership Team

Dean Hum, COO
Charles Woler, Chairman, MBA
Florence Sejourne, Executive
Frederic Desdouits, Executive
Nathalie Huitorel, Executive
Philippe Moons, Executive
Bart Staels, President
Xavier Buttes, Chairman
JeanFrancois Mouney, Chairman

Stock Performance Indicators

Did you try this?

Run Price Exposure Probability Now
   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Price Exposure Probability

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.